Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.

Peter Wipfler (First author), Andrea Harrer (Co-author), Georg Pilz* (Co-author), Katrin Oppermann (Co-author), Eugen Trinka (Co-author), Jörg Kraus (Last author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)8-21
JournalDRUG DISCOVERY TODAY
Volume16
Issue number1-2
DOIs
Publication statusPublished - 2011

Keywords

  • PLACEBO-CONTROLLED TRIAL
  • PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
  • EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
  • STEM-CELL TRANSPLANTATION
  • SUSTAINED-RELEASE FAMPRIDINE
  • HIGH-DOSE CYCLOPHOSPHAMIDE
  • CENTRAL-NERVOUS-SYSTEM
  • OLIGODENDROCYTE PRECURSOR CELLS
  • RANDOMIZED CONTROLLED-TRIAL
  • PARALLEL-GROUP TRIAL

Cite this